from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0902c/prrB

LFCtreatmentdescriptionclass of inhibitor

-0.780

Amikacinug/mL Amikacintranslation

0.307

Cap5-10ug/mL Capreomycintranslation

0.732

Rox10-50 ug/mL Roxithromycintranslation

-0.344

SM2-5 ug/mL Streptomycintranslation

-0.679

Tet5-10 ug/mL Tetracyclinetranslation

-1.274

Rif0.2-5ug/mL Rifampicintranscription

-0.545

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.240

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.065

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.725

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.141

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.207

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.698

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.075

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.126

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.205

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.308

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.358

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.905

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.263

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.078

KCN5-20 ug/mL Potassium cyaniderespiration

0.610

NaN30.2-2 mM Sodium aziderespiration

1.204

Nigericin50 uM Nigericinrespiration

1.078

TRC10-150 ug/mL Triclosanrespiration

0.666

TRZ10-25 ug/mL Thioridazinerespiration

-0.811

Valinomycin0.5-10 uM Valinomycinrespiration

-0.102

ZnSO42 mM ZnSO4respiration

0.172

menadione6-10 ug/mL Menadionerespiration

-0.321

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.422

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.565

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.287

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.680

NRP_1Non-replicating persistence stage 1dosRassociated

0.239

Amp0.2mg/mL AmpicillincellWall

0.168

Cephalexin20-100 ug/mL CephalexincellWall

-0.281

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.373

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.304

EMB10-20 ug/mL EthambutolcellWall

-0.021

Eta12-40 ug/mL EthionamidecellWall

-0.306

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.410

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.062

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.113

BZA0.12 mg/mL BenzamidearomaticAmides

-0.077

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.297

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.624

H2O24 mM hydrogen peroxideDNAdamaging

-0.508

Levo10 ug/mL LevofloxacinDNAdamaging

-0.323

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.090

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.813

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.769

UVUV-irradiationDNAdamaging

-0.776

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.607

Antimycin12.5-50 ug/mL Antimycin A?

0.192

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.320

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.102

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.721

PA8240.2-2 ug/mL PA-824?

0.915

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.215

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.246

Verapamil50 uM Verapamil?

0.291

mercaptoethanol2 mM 2-Mercaptoethanol?

0.114

methoxatin10-20 ug/mL Methoxatin?